Floatz logo

L-HUPERZINE A

Biomarker

Shanghai Mental Health CenterSmall moleculePhase 4 / ApprovedDormant
BB
65/ 100
Provisional rating · Methodology v0.2

Rating breakdown

Clinical Evidence
50/ 100
Competitive Position
95/ 100

Competitive context

0 Active assets in the Biomarker cohort.

Asset / SponsorPhaseRating
Carboplatin
Hao Long
Phase 2CCC
Tislelizumab
Hao Long
Phase 2CCC
FLUOROURACILUM
Fudan University
D

Same molecule, other indications

L-HUPERZINE A is also rated in:

Alzheimer diseaseDormant
BB
Indicative ·
67 / 100
View asset →
DiagnosisDormant
BB
Indicative ·
65 / 100
View asset →
dementiaDormant
B
Indicative ·
62 / 100
View asset →

Need depth?

Order a full diligence report on this asset.

Order report →

Are you the sponsor?

Submit your data room for a Verified Rating. The public-data rating remains visible alongside.

Contact →